Eiger BioPharmaceuticals Zokinvy sale - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF

Representative image illustrating a drone flying over California as reports reveal that Iran allegedly considered a surprise drone strike on targets in the state, according to a Federal Bureau of Investigation intelligence bulletin disclosed during the ongoing United States–Iran conflict.

Iran planned surprise drone strike on California, FBI bulletin reveals

Palantir Technologies (NASDAQ: PLTR) expands Asia enterprise push through LG CNS partnership

What LG CNS and Palantir’s new partnership means for the future of industrial AI adoption

Representative image of the United States Strategic Petroleum Reserve and oil infrastructure as the Trump administration authorises a 172 million barrel SPR drawdown while 32 International Energy Agency nations coordinate the largest emergency oil release in history to stabilise global crude markets.

Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release

Sentynl Therapeutics acquires Eiger BioPharmaceuticals' Zokinvy program, the only FDA-approved treatment for progeria. Read more about this milestone.

Read More

2 minute read

Pharma Industry News

Sentynl Therapeutics acquires Eiger BioPharmaceuticals’ Zokinvy program to expand portfolio in rare diseases

Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly owned by Zydus Lifesciences, Ltd. (Zydus Group), has closed the…

byPallavi Madhiraju

May 4, 2024

web analytics